{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T08:15:45Z","timestamp":1791965745359,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s11095-020-02976-9","type":"journal-article","created":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T15:11:13Z","timestamp":1610723473000},"page":"141-153","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Evaluation of Intranasal Vaccine Delivery Using Anatomical Replicas of Infant Nasal Airways"],"prefix":"10.1007","volume":"38","author":[{"suffix":"Jr","given":"John V.","family":"Wilkins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3450-7160","authenticated-orcid":false,"given":"Laleh","family":"Golshahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nausheen","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,15]]},"reference":[{"key":"2976_CR1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1080\/21645515.2016.1239668","volume":"13","author":"H Yusuf","year":"2017","unstructured":"Yusuf H, Kett V. Current prospects and future challenges for nasal vaccine delivery. Hum Vaccines Immunother. 2017;13:34\u201345.","journal-title":"Hum Vaccines Immunother"},{"key":"2976_CR2","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/jps.21493","volume":"98","author":"S Sharma","year":"2009","unstructured":"Sharma S, Mukkur TKS, Benson HAE, Chen Y. Pharmaceutical aspects of intranasal delivery of vaccines using particulate systems. J Pharm Sci. 2009;98:812\u201343.","journal-title":"J Pharm Sci"},{"key":"2976_CR3","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s13346-012-0085-z","volume":"3","author":"M Zaman","year":"2013","unstructured":"Zaman M, Chandrudu S, Toth I. Strategies for intranasal delivery of vaccines. Drug Deliv Transl Res. 2013;3:100\u20139.","journal-title":"Drug Deliv Transl Res"},{"key":"2976_CR4","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1586\/erv.09.61","volume":"8","author":"Y Yuki","year":"2009","unstructured":"Yuki Y, Kiyono H. Mucosal vaccines: novel advances in technology and delivery. Expert Rev Vaccines. 2009;8:1083\u201397.","journal-title":"Expert Rev Vaccines"},{"key":"2976_CR5","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3109\/1061186X.2010.523790","volume":"18","author":"I Jabbal-Gill","year":"2010","unstructured":"Jabbal-Gill I. Nasal vaccine innovation. J Drug Target. 2010;18:771\u201386.","journal-title":"J Drug Target"},{"key":"2976_CR6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.addr.2005.12.003","volume":"58","author":"EL Giudice","year":"2006","unstructured":"Giudice EL, Campbell JD. Needle-free vaccine delivery. Adv Drug Deliv Rev. 2006;58:68\u201389.","journal-title":"Adv Drug Deliv Rev"},{"key":"2976_CR7","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0168-3659(02)00363-2","volume":"87","author":"L Illum","year":"2003","unstructured":"Illum L. Nasal drug delivery - possibilities, problems and solutions. J Control Release. 2003;87:187\u201398.","journal-title":"J Control Release"},{"key":"2976_CR8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.addr.2014.10.002","volume":"93","author":"JL Tlaxca","year":"2015","unstructured":"Tlaxca JL, Ellis S, Remmele RL. Live attenuated and inactivated viral vaccine formulation and nasal delivery: potential and challenges. Adv Drug Deliv Rev. 2015;93:56\u201378.","journal-title":"Adv Drug Deliv Rev"},{"key":"2976_CR9","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1517\/17425247.2014.931936","volume":"11","author":"P Riese","year":"2014","unstructured":"Riese P, Sakthivel P, Trittel S, Guzm\u00e1n CA. Intranasal formulations: promising strategy to deliver vaccines. Expert Opin Drug Deliv. 2014;11:1619\u201334.","journal-title":"Expert Opin Drug Deliv"},{"key":"2976_CR10","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1023\/B:PHAM.0000041443.17935.33","volume":"21","author":"DT O\u2019Hagan","year":"2004","unstructured":"O\u2019Hagan DT, Rappuoli R. Novel approaches to vaccine delivery. Pharm Res. 2004;21:1519\u201330.","journal-title":"Pharm Res"},{"key":"2976_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0169-409X(01)00162-4","volume":"51","author":"SS Davis","year":"2001","unstructured":"Davis SS. Nasal vaccines. Adv Drug Deliv Rev. 2001;51:21\u201342.","journal-title":"Adv Drug Deliv Rev"},{"key":"2976_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10611860701637966","volume":"16","author":"B Sl\u00fctter","year":"2008","unstructured":"Sl\u00fctter B, Hagenaars N, Jiskoot W. Rational design of nasal vaccines. J Drug Target. 2008;16:1\u201317.","journal-title":"J Drug Target"},{"key":"2976_CR13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s13346-012-0108-9","volume":"3","author":"PG Djupesland","year":"2013","unstructured":"Djupesland PG. Nasal drug delivery devices: characteristics and performance in a clinical perspective-a review. Drug Deliv Transl Res. 2013;3:42\u201362.","journal-title":"Drug Deliv Transl Res."},{"key":"2976_CR14","volume-title":"Subunit vaccine Deliv Adv Deliv Sci Technol","author":"R Scherlie\u00df","year":"2015","unstructured":"Scherlie\u00df R. Nasal administration of vaccines. In: Foged C, Rades T, Perrie Y, Hook S, editors. Subunit vaccine Deliv Adv Deliv Sci Technol. New York: Springer; 2015."},{"key":"2976_CR15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/00006231-199902000-00010","volume":"20","author":"ML Bryant","year":"1999","unstructured":"Bryant ML, Brown P, Gurevich N, McDougall IR. Comparison of the clearance of radiolabelled nose drops and nasal spray as mucosally delivered vaccine. Nucl Med Commun. 1999;20:171\u20134.","journal-title":"Nucl Med Commun"},{"key":"2976_CR16","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1089\/jamp.2014.1174","volume":"28","author":"BL Laube","year":"2015","unstructured":"Laube BL, Sharpless G, Vikani AR, Harrand V, Zinreich SJ, Sedberry K, et al. Intranasal deposition of Accuspray\u2122 aerosol in anatomically correct models of 2-, 5-, and 12-year-old children. J Aerosol Med Pulm Drug Deliv. 2015;28:320\u201333.","journal-title":"J Aerosol Med Pulm Drug Deliv."},{"key":"2976_CR17","unstructured":"Sosnowski TR, Rapiejko P, Sova J, Dobrowolska K. Impact of physicochemical properties of nasal spray products on drug deposition and transport in the pediatric nasal cavity model. Int J Pharm. Elsevier; 2020;574:118911."},{"key":"2976_CR18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1201\/9781315311975-7","volume-title":"Adv Pulm Drug Deliv","author":"RA Tripp","year":"2016","unstructured":"Tripp RA, Hanson JM. Inhaled countermeasures for respiratory tract viruses. In: Kwok PCL, Chan H-K, editors. Adv Pulm Drug Deliv. Boca Raton: Taylor & Francis Group; 2016. p. 93\u2013129."},{"key":"2976_CR19","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1007\/s11095-011-0417-6","volume":"28","author":"V Kundoor","year":"2011","unstructured":"Kundoor V, Dalby RN. Effect of formulation- and administration-related variables on deposition pattern of nasal spray pumps evaluated using a nasal cast. Pharm Res. 2011;28:1895\u2013904.","journal-title":"Pharm Res"},{"key":"2976_CR20","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s11095-016-1896-2","volume":"33","author":"J Xi","year":"2016","unstructured":"Xi J, Yuan JE, Zhang Y, Nevorski D, Wang Z, Zhou Y. Visualization and quantification of nasal and olfactory deposition in a sectional adult nasal airway cast. Pharm Res. 2016;33:1527\u201341.","journal-title":"Pharm Res"},{"key":"2976_CR21","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1089\/jam.2007.0638","volume":"20","author":"MY Foo","year":"2007","unstructured":"Foo MY, Cheng YS, Su WC, Donovan MD. The influence of spray properties on intranasal deposition. J Aerosol Med. 2007;20:495\u2013508.","journal-title":"J Aerosol Med"},{"key":"2976_CR22","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1089\/jamp.2019.1523","volume":"32","author":"S Hosseini","year":"2019","unstructured":"Hosseini S, Wei X, Wilkins JV, Fergusson CP, Mohammadi R, Vorona G, et al. In vitro measurement of regional nasal drug delivery with Flonase,\u00ae Flonase\u00ae Sensimist,\u2122 and MAD Nasal\u2122 in anatomically correct nasal airway replicas of pediatric and adult human subjects. J Aerosol Med Pulm Drug Deliv. 2019;32:374\u201385.","journal-title":"J Aerosol Med Pulm Drug Deliv."},{"key":"2976_CR23","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.jaerosci.2008.07.011","volume":"39","author":"J Storey-Bishoff","year":"2008","unstructured":"Storey-Bishoff J, Noga M, Finlay WH. Deposition of micrometer-sized aerosol particles in neonatal nasal airway replicas. J Aerosol Sci. 2008;39:1055\u201365.","journal-title":"J Aerosol Sci"},{"key":"2976_CR24","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1089\/jamp.2013.1039","volume":"27","author":"Y Zhou","year":"2014","unstructured":"Zhou Y, Guo M, Xi J, Irshad H, Cheng Y-S. Nasal deposition in infants and children. J Aerosol Med Pulm Drug Deliv. 2014;27:110\u20136.","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"2976_CR25","doi-asserted-by":"crossref","unstructured":"Tavernini S, Church TK, Lewis DA, Noga M, Martin AR, Finlay WH. Deposition of micrometer-sized aerosol particles in neonatal nasal airway replicas. Aerosol Sci Technol 2017;0.","DOI":"10.1080\/02786826.2017.1413489"},{"key":"2976_CR26","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1080\/02786826.2011.643257","volume":"46","author":"BL Laube","year":"2011","unstructured":"Laube BL, Sharpless G, Shermer C, Sullivan V, Powell K. Deposition of dry powder generated by Solovent in Sophia anatomical infant nose-throat (SAINT) model. Aerosol Sci Technol. 2011;46:514\u201320.","journal-title":"Aerosol Sci Technol"},{"key":"2976_CR27","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.ijpharm.2019.04.019","volume":"563","author":"S Hosseini","year":"2019","unstructured":"Hosseini S, Golshahi L. An in vitro evaluation of importance of airway anatomy in sub-regional nasal and paranasal drug delivery with nebulizers using three different anatomical nasal airway replicas of 2-, 5- and 50-year old human subjects. Int J Pharm. 2019;563:426\u201336.","journal-title":"Int J Pharm"},{"key":"2976_CR28","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/nri1777","volume":"6","author":"MR Neutra","year":"2006","unstructured":"Neutra MR, Kozlowski PA. Mucosal vaccines: the promise and the challenge. Nat Rev Immunol. 2006;6:148\u201358.","journal-title":"Nat Rev Immunol"},{"key":"2976_CR29","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11095-009-0011-3","volume":"27","author":"O Borges","year":"2010","unstructured":"Borges O, Lebre F, Bento D, Borchard G, Junginger HE. Mucosal vaccines: recent progress in understanding the natural barriers. Pharm Res. 2010;27:211\u201323.","journal-title":"Pharm Res"},{"key":"2976_CR30","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.resp.2012.12.005","volume":"186","author":"XA Si","year":"2013","unstructured":"Si XA, Xi J, Kim JW, Zhou Y, Zhong H. Modeling of release position and ventilation effects on olfactory aerosol drug delivery. Respir Physiol Neurobiol. 2013;186:22\u201332.","journal-title":"Respir Physiol Neurobiol"},{"key":"2976_CR31","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3109\/08958378.2015.1088600","volume":"27","author":"Y Shang","year":"2015","unstructured":"Shang Y, Dong J, Inthavong K, Tu J. Comparative numerical modeling of inhaled micron-sized particle deposition in human and rat nasal cavities. Inhal Toxicol. 2015;27:694\u2013705.","journal-title":"Inhal Toxicol"},{"key":"2976_CR32","unstructured":"ICRP. Human Respiratory Tract Model for Radiological Protection. ICRP Publ 66. 1994;Ann. ICRP."},{"key":"2976_CR33","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1365-2249.2003.02311.x","volume":"134","author":"AS Debertin","year":"2003","unstructured":"Debertin AS, Tschernig T, T\u00f6njes H, Kleemann WJ, Tr\u00f6ger HD, Pabst R. Nasal-associated lymphoid tissue (NALT): frequency and localization in young children. Clin Exp Immunol. 2003;134:503\u20137.","journal-title":"Clin Exp Immunol"},{"key":"2976_CR34","doi-asserted-by":"crossref","unstructured":"Pabst R. Mucosal vaccination by the intranasal route. Nose-associated lymphoid tissue (NALT)-structure, function and species differences. Vaccine. Elsevier Ltd; 2015;33:4406\u20134413.","DOI":"10.1016\/j.vaccine.2015.07.022"},{"key":"2976_CR35","first-page":"4778","volume":"165","author":"FW van Ginkel","year":"2000","unstructured":"van Ginkel FW, Jackson RJ, Yuki Y, McGhee JR. Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues. J Immunol United States. 2000;165:4778\u201382.","journal-title":"J Immunol United States"},{"key":"2976_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0139368","volume":"10","author":"Y Fukuyama","year":"2015","unstructured":"Fukuyama Y, Okada K, Yamaguchi M, Kiyono H, Mori K, Yuki Y. Nasal Administration of Cholera Toxin as a mucosal adjuvant damages the olfactory system in mice. PLoS One. 2015;10:e0139368.","journal-title":"PLoS One"},{"key":"2976_CR37","unstructured":"Wewetzer K, Radtke C, Kocsis J, Baumg\u00e4rtner W. Species-specific control of cellular proliferation and the impact of large animal models for the use of olfactory ensheathing cells and Schwann cells in spinal cord repair. Exp Neurol. Elsevier Inc.; 2011;229:80\u20137."},{"key":"2976_CR38","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00418-011-0796-0","volume":"135","author":"G Brandes","year":"2011","unstructured":"Brandes G, Khayami M, Peck CT, Baumg\u00e4rtner W, Bugday H, Wewetzer K. Cell surface expression of 27C7 by neonatal rat olfactory ensheathing cells in situ and in vitro is independent of axonal contact. Histochem Cell Biol. 2011;135:397\u2013408.","journal-title":"Histochem Cell Biol"},{"key":"2976_CR39","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/ppul.22999","volume":"50","author":"I Amirav","year":"2015","unstructured":"Amirav I, Borojeni AAT, Halamish A, Newhouse MT, Golshahi L. Nasal versus oral aerosol delivery to the \u201clungs\u201d in infants and toddlers. Pediatr Pulmonol. 2015;50:276\u201383.","journal-title":"Pediatr Pulmonol"},{"key":"2976_CR40","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.4187\/respcare.03606","volume":"60","author":"KK El Taoum","year":"2015","unstructured":"El Taoum KK, Xi J, Kim JW, Berlinski A. In vitro evaluation of aerosols delivered via the nasal route. Respir Care. 2015;60:1015\u201325.","journal-title":"Respir Care"},{"key":"2976_CR41","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1177\/000992280104001006","volume":"40","author":"PS Bergeson","year":"2001","unstructured":"Bergeson PS, Shaw JC. Are infants really obligatory nasal breathers? Clin Pediatr (Phila). 2001;40:567\u20139.","journal-title":"Clin Pediatr (Phila)"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-020-02976-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-020-02976-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-020-02976-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T13:44:02Z","timestamp":1614087842000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-020-02976-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["2976"],"URL":"https:\/\/doi.org\/10.1007\/s11095-020-02976-9","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"6 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}